Stock Market
Moderna Earnings Hit by Falling Covid Vaccine Sales
[ad_1]
[ad_2]
Moderna
stock fell early Thursday, wiping out gains from positive news around its cancer vaccine candidate, as fourth-quarter earnings missed expectations.
The biotech company (ticker: MRNA) reported earnings per share of $3.61 in the fourth quarter on revenue of $5.1 billion.
Share this news on your Fb,Twitter and Whatsapp
Times News Network:Latest News Headlines
Times News Network||Health||